Laurus Labs Ltd

Laurus Labs Ltd

LAURUSLABS

 1,355.46
 16.70
1.25%
Healthcare
 0.00
(%)1D
Updated: 26 May 2026, 03:05:28 pm IST
Stock Score
Open Price
 1,344.21
Prev. Close
 1,338.76
 1,339.63
Day Low
 1,357.07
Day High

 581.91
52 Week Low
 1,360.29
52 Week High

Quick Bite

Price To Earnings Ratio

82.35

Sector PE

39.11

PB Ratio

16.44

Sector PB

5.50

EPS

16.46

Dividend Yield

0.20

Today's Volume

1.489 M

5 Day Avg. Volume

1.771 M

PEG Ratio

0.65

Market Cap.

₹ 72,530.00 Cr.

News & Events

About Laurus Labs Ltd

Laurus Labs Limited is an India-based company. The Company is a pharmaceutical manufacturing organization. It is engaged in developing and manufacturing active pharmaceutical ingredients (APIs) and intermediates. It supplies anti-retroviral APIs and intermediates. It provides contract and custom manufacturing solutions, allowing client organizations to outsource various stages of the manufacturing process. It is also engaged in development and manufacturing of animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements catering to the needs of stem cells and regenerative medicine, vaccines and biological drugs, cultured meat, and cell-culture media manufacturing. It offers precision fermentation as a contract development and manufacturing organization (CDMO) service. Its service is offered to protein companies and bio-manufacturers operating across healthcare, food, nutrition, personal care, and bio-based materials markets.

Laurus Labs Ltd Share Price

Laurus Labs Limited is an Indian pharmaceutical and biotechnology company. The company manufactures active ingredients (API) for antiretroviral (ARV), oncology, cardiovascular, diabetes, asthma and gastroenterology. The company also develops and manufactures oral solid formulations, provides contract research and manufacturing services (CRAMS) to other global pharmaceutical companies, and produces specialty ingredients for nutraceuticals, nutraceuticals and cosmetics. The company operates through four business units covering various therapeutic applications, including Generics API, which develops, manufactures and sells APIs and advanced intermediates; Generics Finished Dosage Form (FDF), which develops and manufactures oral solid formulations; Synthesis, which is the main starting materials, intermediates and APIs for New Chemical Entities (NCEs), and Bio, which deals with recombinant products.

Laurus Labs Ltd FAQs

How to Buy Laurus Labs Ltd Share?

up
To purchase Laurus Labs Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Laurus Labs Ltd (ticker symbol: LAURUSLABS) on the trading platform provided by your broker and purchase the shares.

What's Laurus Labs Ltd share price today?

up
The stock price of Laurus Labs Ltd as of 26 May 2026 is ₹1,355.46

What is the Market Cap of Laurus Labs Ltd?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 26 May 2026, Laurus Labs Ltd (ticker symbol: LAURUSLABS) has a market capitalisation of approximately ₹7,25,30,00,00,000.00

What is the PE and PB ratio of Laurus Labs Ltd?

up
Laurus Labs Ltd Ltd's price-to-book ratio as of 26 May 2026 is 16.44, reflecting the market's valuation compared to its asset value. As of 26 May 2026, the trailing twelve months P/E (price-to-earnings) ratio is 82.35, indicating the market values the company at around ₹82.35 for every ₹1 of earnings

What is the 52 Week High and Low of Laurus Labs Ltd Share?

up
Laurus Labs Ltd Ltd (LAURUSLABS) hit its 52-week high at ₹1,360.29, and its 52-week low at ₹581.91.
Begin your investment journey today
Login/Register
Start Now